Evidence map›Paper›PMID 38673075›Full record

ArticleMaterials (Basel, Switzerland)2024

Antimicrobial Photodynamic Therapy Using Encapsulated Protoporphyrin IX for the Treatment of Bacterial Pathogens.

Natalia Izquierdo, Enrique Gamez, Teresa Alejo, Gracia Mendoza, Manuel Arruebo

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Recent Advances in Nanoparticle-Mediated Antibacterial Photodynamic Therapy.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Natalia IzquierdoAragon Health Research Institute (IIS Aragon), 50009 Zaragoza, Spain.
Enrique GamezAragon Health Research Institute (IIS Aragon), 50009 Zaragoza, Spain.ORCID 0000-0002-0272-3152
Teresa AlejoInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain.
Gracia MendozaAragon Health Research Institute (IIS Aragon), 50009 Zaragoza, Spain.ORCID 0000-0003-2293-363X
Manuel ArrueboAragon Health Research Institute (IIS Aragon), 50009 Zaragoza, Spain.ORCID 0000-0003-3165-0156
Universidad de Zaragoza · ESInstituto de Investigación Sanitaria Aragón · ES

Funding

Instituto de Salud Carlos III MS19/00092Instituto de Salud Carlos III PFIS FI22/00131Ministerio de Ciencia e Innovación PDC2021-121405-I00Ministerio de Ciencia e Innovación PID2020-113987RB-I00
6 · The paper itself

Abstract

Herein, we report on the antimicrobial photodynamic effect of polymeric nanoparticles containing the endogenous photosensitizer protoporphyrin IX. Compared to equivalent doses of the free photosensitizer, we demonstrated that the photodynamic antimicrobial efficacy of PLGA (polylactic-co-glycolic acid) nanoparticles containing protoporphyrin IX (PpIX) against pathogenic

Indexed as

encapsulationphotobleachingphotodynamic therapyPLGAprotoporphyrin IXStaphylococcus aureus

Identifiers

PMID38673075
PMCPMC11051101
OpenAlexW4394605585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.